Guidelines for clinical evaluation of chronic kidney disease : AMED research on regulatory science of pharmaceuticals and medical devices

  • Kanda, Eiichiro
    Medical Science, Kawasaki Medical School・Department of Nephrology and Hypertension, Kawasaki Medical School
  • ,
    Department of Nephrology and Hypertension, Kawasaki Medical School
  • Kashihara, Naoki
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health
  • Matsushita, Kunihiro
    Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University
  • Usui, Tomoko
    Department of Nephrology, Saitama Medical University
  • Okada, Hirokazu
    Clinical Research Support Center, Tomishiro Central Hospital
  • Iseki, Kunitoshi
    Office of New Drug I, Pharmaceuticals and Medical Devices Agency (PMDA)
  • Mikami, Kenichi
    Division of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo
  • Tanaka, Tetsuhiro
    Department of Nephrology and Laboratory Medicine, Kanazawa University
  • Wada, Takashi
    Department of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine
  • Watada, Hirotaka
    Diabetes Research Center, National Center for Global Health and Medicine, Tokyo
  • Ueki, Kohjiro
    Division of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo

書誌事項

タイトル別名
  • Guidelines for clinical evaluation of chronic kidney disease

この論文をさがす

抄録

In 2018, Japanese Society of Nephrology established the Research Working Group for Establishing Guidelines for Clinical Evaluation of CKD, which published “Guidelines for Clinical Evaluation of Chronic Kidney Disease” in the Japanese Journal of Nephrology, 2018, vol. 60, issue 2, 67–100. This is the English version of that report. Chairman: Naoki Kashihara.

収録刊行物

被引用文献 (8)*注記

もっと見る

参考文献 (52)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ